Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionstructural constituent of postsynaptic density

DLG2 DLG3

2.50e-0511142GO:0098919
GeneOntologyMolecularFunctionstructural constituent of postsynaptic specialization

DLG2 DLG3

3.54e-0513142GO:0098879
GeneOntologyMolecularFunctionstructural constituent of postsynapse

DLG2 DLG3

2.24e-0432142GO:0099186
GeneOntologyMolecularFunctionstructural constituent of synapse

DLG2 DLG3

3.87e-0442142GO:0098918
GeneOntologyMolecularFunctionionotropic glutamate receptor binding

DLG2 DLG3

5.93e-0452142GO:0035255
GeneOntologyMolecularFunctiontranscription coactivator activity

SS18 ARID1B KAT6A

1.11e-03303143GO:0003713
GeneOntologyMolecularFunctionglutamate receptor binding

DLG2 DLG3

1.43e-0381142GO:0035254
GeneOntologyMolecularFunctioncadherin binding

STK38 CLINT1 BAG3

1.54e-03339143GO:0045296
GeneOntologyMolecularFunctionPDZ domain binding

DLG2 DLG3

3.26e-03123142GO:0030165
GeneOntologyMolecularFunctiontranscription coregulator activity

SS18 ARID1B KAT6A

6.40e-03562143GO:0003712
GeneOntologyMolecularFunctionprotein-macromolecule adaptor activity

STK38 SS18 ARID1B KAT6A

7.09e-031160144GO:0030674
GeneOntologyMolecularFunctioncell adhesion molecule binding

STK38 CLINT1 BAG3

7.64e-03599143GO:0050839
GeneOntologyMolecularFunctionprotein phosphatase binding

DLG2 DLG3

9.22e-03210142GO:0019903
GeneOntologyMolecularFunctionmolecular adaptor activity

STK38 SS18 ARID1B KAT6A

1.22e-021356144GO:0060090
GeneOntologyMolecularFunctionmagnesium ion binding

STK38 STK38L

1.26e-02247142GO:0000287
GeneOntologyMolecularFunctionphosphatase binding

DLG2 DLG3

1.43e-02264142GO:0019902
GeneOntologyMolecularFunctionkinase activity

STK38 STK38L DLG2

1.48e-02764143GO:0016301
GeneOntologyBiologicalProcessprotein transport along microtubule

DLG2 BAG3

4.96e-0517132GO:0098840
GeneOntologyBiologicalProcessmicrotubule-based protein transport

DLG2 BAG3

4.96e-0517132GO:0099118
GeneOntologyCellularComponentnpBAF complex

SS18 ARID1B

3.24e-0514132GO:0071564
GeneOntologyCellularComponentSWI/SNF complex

SS18 ARID1B

1.54e-0430132GO:0016514
GeneOntologyCellularComponentglutamatergic synapse

STK38 STK38L DLG2 DLG3

1.25e-03817134GO:0098978
GeneOntologyCellularComponentchromatin

TBX15 SS18 REL ARID1B KAT6A

1.41e-031480135GO:0000785
GeneOntologyCellularComponentSWI/SNF superfamily-type complex

SS18 ARID1B

1.58e-0396132GO:0070603
GeneOntologyCellularComponentneuromuscular junction

DLG2 DLG3

2.14e-03112132GO:0031594
GeneOntologyCellularComponentATPase complex

SS18 ARID1B

2.82e-03129132GO:1904949
GeneOntologyCellularComponentpostsynaptic density membrane

DLG2 DLG3

4.14e-03157132GO:0098839
DomainMAGUK_N_PEST

DLG2 DLG3

3.13e-064142SM01277
DomainDLG1

DLG2 DLG3

3.13e-064142IPR016313
DomainDLG1_PEST_dom

DLG2 DLG3

3.13e-064142IPR019590
DomainPDZ_assoc

DLG2 DLG3

3.13e-064142IPR019583
DomainMAGUK_N_PEST

DLG2 DLG3

3.13e-064142PF10608
DomainPDZ_assoc

DLG2 DLG3

3.13e-064142PF10600
DomainDUF3699

GARIN4 GARIN6

1.87e-059142IPR022168
DomainDUF3699

GARIN4 GARIN6

1.87e-059142PF12480
DomainGuanylate_kinase_CS

DLG2 DLG3

6.22e-0516142IPR020590
DomainGUANYLATE_KINASE_2

DLG2 DLG3

1.31e-0423142PS50052
DomainGUANYLATE_KINASE_1

DLG2 DLG3

1.31e-0423142PS00856
DomainGuanylate_kin

DLG2 DLG3

1.68e-0426142PF00625
DomainGuKc

DLG2 DLG3

1.68e-0426142SM00072
DomainGK/Ca_channel_bsu

DLG2 DLG3

1.68e-0426142IPR008145
DomainGuanylate_kin-like_dom

DLG2 DLG3

1.68e-0426142IPR008144
DomainPkinase_C

STK38 STK38L

3.42e-0437142IPR017892
DomainPkinase_C

STK38 STK38L

4.42e-0442142PF00433
Domainp53-like_TF_DNA-bd

TBX15 REL

7.03e-0453142IPR008967
DomainAGC-kinase_C

STK38 STK38L

7.85e-0456142IPR000961
DomainAGC_KINASE_CTER

STK38 STK38L

7.85e-0456142PS51285
DomainS_TK_X

STK38 STK38L

7.85e-0456142SM00133
DomainPDZ

DLG2 DLG3

4.85e-03141142PF00595
DomainPDZ

DLG2 DLG3

5.33e-03148142SM00228
Domain-

DLG2 DLG3

5.47e-031501422.30.42.10
DomainPDZ

DLG2 DLG3

5.54e-03151142PS50106
DomainPDZ

DLG2 DLG3

5.62e-03152142IPR001478
DomainSH3_1

DLG2 DLG3

6.51e-03164142PF00018
DomainSH3

DLG2 DLG3

1.11e-02216142PS50002
DomainSH3

DLG2 DLG3

1.11e-02216142SM00326
DomainSH3_domain

DLG2 DLG3

1.15e-02220142IPR001452
DomainSer/Thr_kinase_AS

STK38 STK38L

2.85e-02357142IPR008271
DomainS_TKc

STK38 STK38L

2.88e-02359142SM00220
DomainPROTEIN_KINASE_ST

STK38 STK38L

2.92e-02362142PS00108
DomainProtein_kinase_ATP_BS

STK38 STK38L

3.18e-02379142IPR017441
DomainPkinase

STK38 STK38L

3.21e-02381142PF00069
PathwayBIOCARTA_PDZS_PATHWAY

DLG2 DLG3

8.41e-0518112M22001
PathwayREACTOME_RAS_ACTIVATION_UPON_CA2_INFLUX_THROUGH_NMDA_RECEPTOR

DLG2 DLG3

1.04e-0420112M17670
PathwayREACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION

DLG2 DLG3

1.15e-0421112M838
PathwayREACTOME_NEGATIVE_REGULATION_OF_NMDA_RECEPTOR_MEDIATED_NEURONAL_TRANSMISSION

DLG2 DLG3

1.15e-0421112M27944
PathwayREACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION

DLG2 DLG3

1.27e-0422112MM15104
PathwayREACTOME_LONG_TERM_POTENTIATION

DLG2 DLG3

1.39e-0423112M27949
PathwayREACTOME_CREB1_PHOSPHORYLATION_THROUGH_NMDA_RECEPTOR_MEDIATED_ACTIVATION_OF_RAS_SIGNALING

DLG2 DLG3

2.07e-0428112M837
PathwayREACTOME_NEUREXINS_AND_NEUROLIGINS

DLG2 DLG3

2.71e-0432112MM15326
PathwayREACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS

DLG2 DLG3

3.25e-0435112MM15109
PathwayREACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION

SS18 ARID1B

4.69e-0442112M48237
PathwayREACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS

DLG2 DLG3

5.14e-0444112M27934
PathwayREACTOME_NEUREXINS_AND_NEUROLIGINS

DLG2 DLG3

8.33e-0456112M27616
PathwayREACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES

DLG2 DLG3

1.19e-0367112MM15327
PathwayREACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES

DLG2 DLG3

2.00e-0387112M27617
PathwayREACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS

DLG2 DLG3

2.33e-0394112M2843
PathwayREACTOME_MITF_M_DEPENDENT_GENE_EXPRESSION

SS18 ARID1B

2.38e-0395112M48268
PathwayREACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_PIWI_INTERACTING_RNAS_PIRNAS

SS18 ARID1B

2.48e-0397112M48262
PathwayWP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION

DLG2 DLG3

4.53e-03132112M48110
PathwayREACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT

SS18 ARID1B

4.87e-03137112M48232
PathwayREACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS

SS18 ARID1B

5.22e-03142112M48257
PathwayREACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION

DLG2 DLG3

5.37e-03144112MM14501
PathwayREACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION

DLG2 DLG3

1.06e-02205112M752
Pubmed

NDR functions as a physiological YAP1 kinase in the intestinal epithelium.

STK38 STK38L

1.50e-07214225601544
Pubmed

Regulation of NDR2 protein kinase by multi-site phosphorylation and the S100B calcium-binding protein.

STK38 STK38L

1.50e-07214215037617
Pubmed

Cyclin D1 promotes cell cycle progression through enhancing NDR1/2 kinase activity independent of cyclin-dependent kinase 4.

STK38 STK38L

4.51e-07314223897809
Pubmed

Calcium-permeable AMPA receptors and silent synapses in cocaine-conditioned place preference.

DLG2 DLG3

4.51e-07314228077487
Pubmed

A brain atlas of synapse protein lifetime across the mouse lifespan.

DLG2 DLG3

4.51e-07314236202095
Pubmed

Human NDR kinases control G(1)/S cell cycle transition by directly regulating p21 stability.

STK38 STK38L

4.51e-07314221262772
Pubmed

Architecture of the Mouse Brain Synaptome.

DLG2 DLG3

4.51e-07314230078578
Pubmed

Synapse-specific and developmentally regulated targeting of AMPA receptors by a family of MAGUK scaffolding proteins.

DLG2 DLG3

4.51e-07314217046693
Pubmed

HIV-1 incorporates and proteolytically processes human NDR1 and NDR2 serine-threonine kinases.

STK38 STK38L

4.51e-07314215582665
Pubmed

MAGUKs are essential, but redundant, in long-term potentiation.

DLG2 DLG3

4.51e-07314234244435
Pubmed

Postsynaptic density scaffold SAP102 regulates cortical synapse development through EphB and PAK signaling pathway.

DLG2 DLG3

4.51e-07314223486974
Pubmed

NDR kinase is activated by RASSF1A/MST1 in response to Fas receptor stimulation and promotes apoptosis.

STK38 STK38L

9.02e-07414219062280
Pubmed

Expression pattern of membrane-associated guanylate kinases in interneurons of the visual cortex.

DLG2 DLG3

9.02e-07414221031555
Pubmed

Synaptic scaffold evolution generated components of vertebrate cognitive complexity.

DLG2 DLG3

9.02e-07414223201973
Pubmed

Mechanism of activation of NDR (nuclear Dbf2-related) protein kinase by the hMOB1 protein.

STK38 STK38L

9.02e-07414215197186
Pubmed

The neuregulin receptor ErbB-4 interacts with PDZ-containing proteins at neuronal synapses.

DLG2 DLG3

1.50e-06514210725395
Pubmed

Selective interaction of megalin with postsynaptic density-95 (PSD-95)-like membrane-associated guanylate kinase (MAGUK) proteins.

DLG2 DLG3

1.50e-06514212713445
Pubmed

Sema4c, a transmembrane semaphorin, interacts with a post-synaptic density protein, PSD-95.

DLG2 DLG3

1.50e-06514211134026
Pubmed

Ndr kinases regulate retinal interneuron proliferation and homeostasis.

STK38 STK38L

1.50e-06514230135513
Pubmed

Human Mob proteins regulate the NDR1 and NDR2 serine-threonine kinases.

STK38 STK38L

1.50e-06514215067004
Pubmed

Preso, a novel PSD-95-interacting FERM and PDZ domain protein that regulates dendritic spine morphogenesis.

DLG2 DLG3

2.25e-06614219118189
Pubmed

Guanylyl cyclase/PSD-95 interaction: targeting of the nitric oxide-sensitive alpha2beta1 guanylyl cyclase to synaptic membranes.

DLG2 DLG3

2.25e-06614211572861
Pubmed

Selective binding of synapse-associated protein 97 to GluR-A alpha-amino-5-hydroxy-3-methyl-4-isoxazole propionate receptor subunit is determined by a novel sequence motif.

DLG2 DLG3

2.25e-06614212070168
Pubmed

Loss of NDR1/2 kinases impairs endomembrane trafficking and autophagy leading to neurodegeneration.

STK38 STK38L

2.25e-06614236446521
Pubmed

Plasma membrane Ca2+-atpase isoforms 2b and 4b interact promiscuously and selectively with members of the membrane-associated guanylate kinase family of PDZ (PSD95/Dlg/ZO-1) domain-containing proteins.

DLG2 DLG3

2.25e-06614211274188
Pubmed

Neto1 is a novel CUB-domain NMDA receptor-interacting protein required for synaptic plasticity and learning.

DLG2 DLG3

3.16e-06714219243221
Pubmed

A tripartite protein complex with the potential to couple synaptic vesicle exocytosis to cell adhesion in brain.

DLG2 DLG3

3.16e-0671429753324
Pubmed

Reversible disruption of mSWI/SNF (BAF) complexes by the SS18-SSX oncogenic fusion in synovial sarcoma.

SS18 ARID1B

3.16e-06714223540691
Pubmed

Inward rectifier K+ channel Kir2.3 is localized at the postsynaptic membrane of excitatory synapses.

DLG2 DLG3

3.16e-06714211997254
Pubmed

Polarity protein complex Scribble/Lgl/Dlg and epithelial cell barriers.

DLG2 DLG3

4.21e-06814223397623
Pubmed

Identification of multiple binding partners for the amino-terminal domain of synapse-associated protein 97.

DLG2 DLG3

4.21e-06814212351654
Pubmed

Btbd11 supports cell-type-specific synaptic function.

DLG2 DLG3

4.21e-06814237261953
Pubmed

Binding of neuroligins to PSD-95.

DLG2 DLG3

5.41e-0691429278515
Pubmed

Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers.

STK38 STK38L ARID1B OVGP1 KAT6A

6.88e-0673014534857952
Pubmed

DGKι regulates presynaptic release during mGluR-dependent LTD.

DLG2 DLG3

8.26e-061114221119615
Pubmed

NGL family PSD-95-interacting adhesion molecules regulate excitatory synapse formation.

DLG2 DLG3

9.91e-061214216980967
Pubmed

SYT associates with human SNF/SWI complexes and the C-terminal region of its fusion partner SSX1 targets histones.

SS18 ARID1B

9.91e-061214211734557
Pubmed

Rescue of deficits by Brwd1 copy number restoration in the Ts65Dn mouse model of Down syndrome.

SS18 ARID1B

1.37e-051414236289231
Pubmed

Kinetic analysis of npBAF to nBAF switching reveals exchange of SS18 with CREST and integration with neural developmental pathways.

SS18 ARID1B

1.58e-051514223785148
Pubmed

Dlg3 trafficking and apical tight junction formation is regulated by nedd4 and nedd4-2 e3 ubiquitin ligases.

DLG2 DLG3

1.80e-051614221920314
Pubmed

Binding of USP4 to cortactin enhances cell migration in HCT116 human colon cancer cells.

STK38 CLINT1 BAG3

2.11e-0513714337039823
Pubmed

Targeted tandem affinity purification of PSD-95 recovers core postsynaptic complexes and schizophrenia susceptibility proteins.

DLG2 DLG3

2.29e-051814219455133
Pubmed

Jumonji modulates polycomb activity and self-renewal versus differentiation of stem cells.

STK38 STK38L

2.29e-051814220064376
Pubmed

Protein trafficking and anchoring complexes revealed by proteomic analysis of inward rectifier potassium channel (Kir2.x)-associated proteins.

DLG2 DLG3

2.56e-051914215024025
Pubmed

The Epigenetic Factor Landscape of Developing Neocortex Is Regulated by Transcription Factors Pax6→ Tbr2→ Tbr1.

SS18 ARID1B KAT6A

3.17e-0515714330186101
Pubmed

FET family fusion oncoproteins target the SWI/SNF chromatin remodeling complex.

SS18 ARID1B

3.79e-052314230962207
Pubmed

Uncovering quantitative protein interaction networks for mouse PDZ domains using protein microarrays.

DLG2 DLG3

3.79e-052314216637659
Pubmed

SALM4 suppresses excitatory synapse development by cis-inhibiting trans-synaptic SALM3-LAR adhesion.

DLG2 DLG3

4.49e-052514227480238
Pubmed

Glioma tumor suppressor candidate region gene 1 (GLTSCR1) and its paralog GLTSCR1-like form SWI/SNF chromatin remodeling subcomplexes.

SS18 ARID1B

5.25e-052714229374058
Pubmed

Eda-activated RelB recruits an SWI/SNF (BAF) chromatin-remodeling complex and initiates gene transcription in skin appendage formation.

REL ARID1B

5.65e-052814230037996
Pubmed

BioID Performed on Golgi Enriched Fractions Identify C10orf76 as a GBF1 Binding Protein Essential for Golgi Maintenance and Secretion.

STK38 CLINT1 BAG3

8.18e-0521614331519766
Pubmed

Quantifying domain-ligand affinities and specificities by high-throughput holdup assay.

DLG2 DLG3

9.41e-053614226053890
Pubmed

Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization.

STK38 STK38L CLINT1

1.34e-0425514315324660
Pubmed

SUMO-specific protease 2 (SENP2) suppresses keratinocyte migration by targeting NDR1 for de-SUMOylation.

STK38 STK38L

1.54e-044614229969578
Pubmed

MDM2 mediates nonproteolytic polyubiquitylation of the DEAD-Box RNA helicase DDX24.

STK38 STK38L

1.82e-045014224980433
Pubmed

Comprehensive analysis of interactions between the Src-associated protein in mitosis of 68 kDa and the human Src-homology 3 proteome.

DLG2 DLG3

2.29e-045614222745667
Pubmed

Investigation of genetic susceptibility factors for human longevity - a targeted nonsynonymous SNP study.

OVGP1 KAT6A BAG3

2.44e-0431314320800603
Pubmed

A lentiviral functional proteomics approach identifies chromatin remodeling complexes important for the induction of pluripotency.

SS18 ARID1B

2.72e-046114220305087
Pubmed

Assembly of the WHIP-TRIM14-PPP6C Mitochondrial Complex Promotes RIG-I-Mediated Antiviral Signaling.

STK38 CLINT1 BAG3

2.90e-0433214329053956
Pubmed

Loss of BAF (mSWI/SNF) Complexes Causes Global Transcriptional and Chromatin State Changes in Forebrain Development.

SS18 ARID1B

3.08e-046514226655900
Pubmed

Comprehensive copy number variant (CNV) analysis of neuronal pathways genes in psychiatric disorders identifies rare variants within patients.

DLG2 CLINT1

3.28e-046714220398908
InteractionEXOSC1 interactions

STK38 REL KAT6A BAG3

8.67e-07112144int:EXOSC1
InteractionAOAH interactions

DLG2 DLG3

2.69e-064142int:AOAH
InteractionKCNJ2 interactions

STK38 DLG2 DLG3

3.02e-0642143int:KCNJ2
InteractionSTK38L interactions

STK38 STK38L KAT6A

1.89e-0577143int:STK38L
InteractionRAB2B interactions

GARIN4 GARIN6 BAG3

2.21e-0581143int:RAB2B
InteractionNR2C2AP interactions

REL BAG3

4.06e-0514142int:NR2C2AP
InteractionGUCY1A2 interactions

DLG2 DLG3

6.81e-0518142int:GUCY1A2
InteractionDLG3 interactions

DLG2 DLG3 BAG3

9.27e-05131143int:DLG3
InteractionNLGN1 interactions

DLG2 DLG3

1.03e-0422142int:NLGN1
InteractionGLS2 interactions

DLG2 DLG3

1.23e-0424142int:GLS2
InteractionHSPB7 interactions

REL BAG3

1.23e-0424142int:HSPB7
InteractionSEC16A interactions

STK38 REL CLINT1 BAG3

1.67e-04426144int:SEC16A
InteractionKCNJ12 interactions

DLG2 DLG3

1.68e-0428142int:KCNJ12
InteractionCRIPT interactions

DLG2 DLG3

1.68e-0428142int:CRIPT
InteractionASL interactions

OVGP1 BAG3

1.93e-0430142int:ASL
InteractionCACNG2 interactions

DLG2 DLG3

2.34e-0433142int:CACNG2
InteractionS100A1 interactions

REL BAG3

3.27e-0439142int:S100A1
InteractionDLGAP2 interactions

DLG2 DLG3

3.27e-0439142int:DLGAP2
InteractionPRPH interactions

STK38 STK38L BAG3

3.43e-04204143int:PRPH
InteractionBMF interactions

REL BAG3

3.80e-0442142int:BMF
InteractionDLGAP3 interactions

DLG2 DLG3

4.17e-0444142int:DLGAP3
InteractionSCN5A interactions

DLG2 DLG3

4.76e-0447142int:SCN5A
InteractionNAP1L5 interactions

STK38L BAG3

6.05e-0453142int:NAP1L5
InteractionCGGBP1 interactions

REL KAT6A

6.28e-0454142int:CGGBP1
InteractionJARID2 interactions

STK38 STK38L

6.28e-0454142int:JARID2
InteractionMOB1B interactions

STK38 STK38L

6.28e-0454142int:MOB1B
InteractionABCA1 interactions

DLG2 DLG3

6.28e-0454142int:ABCA1
InteractionCPSF1 interactions

REL ARID1B KAT6A

6.57e-04255143int:CPSF1
InteractionWNK3 interactions

REL CLINT1

6.75e-0456142int:WNK3
InteractionPBRM1 interactions

SS18 ARID1B KAT6A

6.80e-04258143int:PBRM1
InteractionCALM1 interactions

STK38 DLG3 REL CLINT1

7.20e-04626144int:CALM1
InteractionLIN7A interactions

DLG2 DLG3

7.50e-0459142int:LIN7A
InteractionFLI1 interactions

SS18 ARID1B

8.27e-0462142int:FLI1
InteractionBANP interactions

STK38 REL GARIN6

8.36e-04277143int:BANP
InteractionPRDM10 interactions

REL KAT6A

8.81e-0464142int:PRDM10
InteractionUBE2Z interactions

REL BAG3

9.09e-0465142int:UBE2Z
InteractionCNKSR2 interactions

DLG2 DLG3

9.37e-0466142int:CNKSR2
InteractionTLX3 interactions

TBX15 REL ARID1B

9.64e-04291143int:TLX3
InteractionBICRA interactions

SS18 ARID1B

9.66e-0467142int:BICRA
InteractionUSP4 interactions

STK38 CLINT1 BAG3

9.83e-04293143int:USP4
InteractionKCNA4 interactions

DLG2 DLG3

9.94e-0468142int:KCNA4
InteractionGCM1 interactions

SS18 ARID1B

9.94e-0468142int:GCM1
InteractionETV4 interactions

SS18 ARID1B

1.02e-0369142int:ETV4
InteractionNLGN2 interactions

DLG2 DLG3

1.02e-0369142int:NLGN2
InteractionPOLE2 interactions

TBX15 REL

1.02e-0369142int:POLE2
InteractionPIH1D2 interactions

REL BAG3

1.08e-0371142int:PIH1D2
InteractionMOB1A interactions

STK38 STK38L

1.11e-0372142int:MOB1A
InteractionMAP3K2 interactions

STK38 STK38L

1.14e-0373142int:MAP3K2
InteractionSTAMBPL1 interactions

REL CLINT1

1.21e-0375142int:STAMBPL1
InteractionSS18L2 interactions

DLG3 ARID1B

1.24e-0376142int:SS18L2
InteractionGPC4 interactions

REL BAG3

1.34e-0379142int:GPC4
InteractionDLG2 interactions

DLG2 DLG3

1.48e-0383142int:DLG2
InteractionIRF1 interactions

SS18 ARID1B

1.48e-0383142int:IRF1
InteractionSTK11IP interactions

SS18 ARID1B

1.48e-0383142int:STK11IP
InteractionIRF4 interactions

SS18 ARID1B

1.55e-0385142int:IRF4
InteractionGRIA1 interactions

DLG2 DLG3

1.58e-0386142int:GRIA1
InteractionMAPK12 interactions

DLG2 DLG3

1.58e-0386142int:MAPK12
InteractionNFKBIB interactions

REL BAG3

1.58e-0386142int:NFKBIB
InteractionDPF2 interactions

SS18 REL ARID1B

1.63e-03349143int:DPF2
InteractionCMBL interactions

STK38L BAG3

1.66e-0388142int:CMBL
InteractionSS18 interactions

SS18 ARID1B

1.66e-0388142int:SS18
InteractionKAT5 interactions

STK38 ARID1B KAT6A

1.75e-03358143int:KAT5
InteractionSMARCB1 interactions

SS18 ARID1B KAT6A

1.83e-03364143int:SMARCB1
InteractionGRIN2A interactions

DLG2 DLG3

1.85e-0393142int:GRIN2A
InteractionPLEKHA2 interactions

DLG2 DLG3

1.89e-0394142int:PLEKHA2
InteractionCRK interactions

STK38 KAT6A BAG3

1.92e-03370143int:CRK
InteractionBCL7B interactions

SS18 ARID1B

1.93e-0395142int:BCL7B
InteractionSOX17 interactions

SS18 ARID1B

1.93e-0395142int:SOX17
InteractionDPF3 interactions

SS18 ARID1B

1.93e-0395142int:DPF3
InteractionDPF1 interactions

SS18 ARID1B

1.93e-0395142int:DPF1
InteractionCDKN1A interactions

SS18 REL CLINT1

2.00e-03375143int:CDKN1A
InteractionSCN4A interactions

DLG2 DLG3

2.05e-0398142int:SCN4A
InteractionSS18L1 interactions

SS18 ARID1B

2.05e-0398142int:SS18L1
InteractionNLGN3 interactions

DLG2 DLG3

2.09e-0399142int:NLGN3
InteractionKDELR1 interactions

DLG2 DLG3

2.09e-0399142int:KDELR1
InteractionTRIM14 interactions

STK38 CLINT1 BAG3

2.12e-03383143int:TRIM14
InteractionCPNE2 interactions

REL BAG3

2.13e-03100142int:CPNE2
GeneFamilyCalcium voltage-gated channel subunits|Membrane associated guanylate kinases

DLG2 DLG3

5.54e-052682904
GeneFamilyPDZ domain containing

DLG2 DLG3

1.90e-03152821220
GeneFamilyArmadillo repeat containing|Protein phosphatase 1 regulatory subunits

DLG2 DLG3

2.68e-0318182694
CoexpressionGSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_48H_CD4_TCELL_UP

OVGP1 KAT6A BAG3

1.27e-04189143M4199
CoexpressionGSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_24H_CD4_TCELL_UP

OVGP1 KAT6A BAG3

1.39e-04195143M4195
CoexpressionGSE28408_LY6G_POS_VS_NEG_DC_UP

STK38 KAT6A BAG3

1.43e-04197143M9547
CoexpressionGSE22886_IGG_IGA_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_DN

SS18 CLINT1 BAG3

1.45e-04198143M4446
CoexpressionGSE36826_WT_VS_IL1R_KO_SKIN_DN

STK38L REL KAT6A

1.45e-04198143M9530
CoexpressionGSE12392_IFNAR_KO_VS_IFNB_KO_CD8_NEG_SPLEEN_DC_UP

REL KAT6A BAG3

1.48e-04199143M7142
CoexpressionGSE22886_IGG_IGA_MEMORY_BCELL_VS_BM_PLASMA_CELL_UP

STK38 REL KAT6A

1.50e-04200143M4449
CoexpressionXIE_TRASTUZUMAB_CARDIOTOXICITY_MMU_MIR_329_3P_GENES

SS18 ARID1B

1.56e-0435142MM17501
ToppCell343B-Myeloid-Dendritic-cDC2|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

STK38L DLG3 REL BAG3

3.24e-07194144ccb04f0788c98e0f63f18b09484d75ac536412a1
ToppCelldroplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

REL CLINT1 KAT6A

2.29e-05182143f8c73baaaca145e2efc48f10f636feb79c8fc779
ToppCelldroplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

REL CLINT1 KAT6A

2.37e-051841431154a5ad7b8512272b7476f949ddac350910bfb7
ToppCelldroplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

REL CLINT1 KAT6A

2.41e-051851437adfa929930cfa795cbfbd9f1a0b439e08aa765d
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

REL OVGP1 BAG3

2.90e-05197143b597c292fc1cb381a4325fed15a32966c38def28
ToppCellfrontal_cortex-Neuronal-glutamatergic_neuron-CR|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

TBX15 BAG3

3.24e-048614297467708c90a4bd49deafe3e2ec495c56b448ce1
ToppCellfrontal_cortex-Neuronal-glutamatergic_neuron-CR-CR_Lhx5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

TBX15 BAG3

3.24e-04861422990429ed4438f41ff03f4a9cae8863a528fdd81
ToppCellSmart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_monocytic-monocyte|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

GARIN4 BAG3

6.82e-04125142a72891c3fb9cdefa9254f8e2e3c4ffa6fc3a5ffc
ToppCellIonocyte-iono-4|World / Class top

DLG2 REL

7.26e-0412914285ee6e16959cb58a58f5b09edf1f78d9ce6a9441
ToppCellPND07-28-samps-Mesenchymal-Myofibroblast-MyoFB-3|PND07-28-samps / Age Group, Lineage, Cell class and subclass

DLG3 CLINT1

8.66e-041411427ae8ead02e5aeb4106c4a30c08a7a061da3a5d6a
ToppCellfacs-Marrow-B-cells-24m-Lymphocytic-early_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TBX15 DLG2

9.03e-04144142d3f6f5da56794367ee3776bfd3a9dcf893efe0f0
ToppCellfacs-Marrow-B-cells-24m-Lymphocytic-early_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TBX15 DLG2

9.03e-041441421d05aa08603cba28c0c6511767e434c1f592a3aa
ToppCell3'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

REL BAG3

1.04e-0315514277ae0b8d30bc3db4a73fd5340f99691a73d2684f
ToppCell356C-Myeloid-Macrophage-SPP1+_Macrophage_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells)

STK38L REL

1.07e-031571427ceae5fe00c91d4feb8c314d3a31f027c03fa56f
ToppCellfacs-Brain_Non-Myeloid-Cortex_-18m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DLG2 CLINT1

1.13e-0316114269f5e759c0925daa37e0177a9cc3154842906bf6
ToppCellChildren_(3_yrs)-Immune-dendritic_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

STK38L REL

1.13e-03161142cd41abb7ae659d3d314281783a0aaad562b26037
ToppCell10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

GARIN4 REL

1.15e-03163142a6e272e043859858084b8d4d96fa4ff9e6eca454
ToppCell3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TBX15 DLG2

1.17e-0316414257301178e420983c0cb72178e288a3a0449fdda3
ToppCellfacs-Marrow-T_cells-18m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DLG2 OVGP1

1.18e-031651420edd56e8d14eaeced9882dd9206ea93e8f402e8d
ToppCellfacs-Brain_Non-Myeloid-Cortex_-18m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DLG2 CLINT1

1.18e-0316514202cd87dfa2ca40e13455a4b9308477e82f76289b
ToppCellfacs-Marrow-T_cells-18m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DLG2 OVGP1

1.18e-03165142fa3aadfff6fb1e7f142db333c60c2cba02b17e6c
ToppCellfacs-Brain_Non-Myeloid-Cortex_-18m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DLG2 CLINT1

1.18e-031651426d8b5669eee9b0903c9260fea707d186c9d7fefa
ToppCellCOVID-19-Myeloid-MoAM5,_CCL3L1|Myeloid / Condition, Lineage and Cell class

STK38L REL

1.22e-03168142ea465152ea31391b63c02425beafa9a4f51f6703
ToppCelldroplet-Lung-18m-Hematologic-myeloid-non-classical_monocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

STK38 REL

1.22e-03168142689c41f6e9f65381570991cc311cba49a57ec955
ToppCelldroplet-Lung-18m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

STK38 REL

1.22e-031681424b5be7c6662eceddf90a65015f12908278d1664e
ToppCellMild/Remission-B_naive-4|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)

REL KAT6A

1.24e-03169142c3a6179a64589a370108fea809b157839347759c
ToppCelldroplet-Lung-nan-18m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

STK38 REL

1.24e-03169142c96e0f3241d13926dbee9f91c0c8c5bfa7479a0d
ToppCelldroplet-Lung-nan-18m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

STK38 REL

1.24e-03169142ba023ee7bb165c2bfbefc2d969ff32ca1eeed33b
ToppCelldroplet-Lung-nan-18m-Myeloid-Plasmacytoid_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DLG2 CLINT1

1.25e-03170142749144a1a869a6bf9acdd227184319083367dc3f
ToppCellkidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

DLG2 ARID1B

1.25e-03170142928e42c51a7079c506f21c669c4e4c1a0df84d77
ToppCelldroplet-Lung-nan-18m-Myeloid-plasmacytoid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DLG2 CLINT1

1.25e-0317014225d60a62e8f99c31ab64fe6a0c07ccca3df1a7ee
ToppCelldroplet-Kidney-nan-21m-Myeloid-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

STK38L CLINT1

1.25e-03170142510625bd725d3590cffcd7acd1d42219f6eb1139
ToppCelldroplet-Lung-18m-Hematologic-myeloid-plasmacytoid_dendritic_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

DLG2 CLINT1

1.28e-031721421abb6fbb28c8aff384540493d0f70eeacaa751f4
ToppCellfacs-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

REL CLINT1

1.28e-0317214248d0cfc37d1b1ae48ed8f8b2711abeb609d2bb6e
ToppCelldroplet-Lung-18m-Hematologic-myeloid-plasmacytoid_dendritic_cell-plasmacytoid_dendritic|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

DLG2 CLINT1

1.28e-03172142422d311bba2dd5d8bece4e96ee8c86e78086b62d
ToppCellMild/Remission-B_naive-8|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)

REL ARID1B

1.30e-03173142694d02c4d2dc2de4b344544f9124fec40fcf7d8f
ToppCellCOVID-19-Myeloid-MoAM5,_CCL3L1|COVID-19 / Condition, Lineage and Cell class

STK38L REL

1.30e-03173142502f888b7684ed39f5c577eedcacf673ae81d39e
ToppCellTCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Non-keratinizing_Cervical_Squamous_Cell_Carcinoma-3|TCGA-Cervix / Sample_Type by Project: Shred V9

REL BAG3

1.33e-031751420cc215109d9915af47e4d0a120ce2e46910715fa
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

DLG2 OVGP1

1.34e-0317614266c9c6b59030f67e8d746a9c6930e50923f2ded1
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

DLG2 OVGP1

1.34e-03176142b4a23d8d1414434adeb237a96f28c825f1aebd77
ToppCell356C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|356C / Donor, Lineage, Cell class and subclass (all cells)

TBX15 GARIN4

1.34e-031761422287bd8382f41e36ebb0875a0133bada1ec81fa7
ToppCell356C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|356C / Donor, Lineage, Cell class and subclass (all cells)

TBX15 GARIN4

1.34e-03176142135d51d28a7ad2a67d5a6c49eb6e661f4beb66f5
ToppCell10x3'2.3-week_14-16-Myeloid_neutrophil-granulo-eo/baso/mast-basophil|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

STK38L CLINT1

1.34e-03176142581d78811b2d99f38a2c7cc268aeb1cf932379c2
ToppCellSevere-CD4+_T_activated|World / Disease group and Cell class

GARIN4 BAG3

1.37e-03178142ef6111238703579a34bd6948bd9d4ca6b7e16063
ToppCellfacs-Heart-RA-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

REL CLINT1

1.37e-03178142b505e2550860e777535ee95f29c936242fd607f1
ToppCellremission-B_naive|World / disease stage, cell group and cell class

GARIN4 REL

1.43e-03182142cc1dfd2de35aee1a26f7efd78e108b60a3556ec5
ToppCellremission-B_naive|remission / disease stage, cell group and cell class

GARIN4 REL

1.45e-03183142280d55d67f1d44594206da2f3a332c9d799dbdf0
ToppCellLV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper

DLG2 GARIN4

1.47e-03184142ab7a1620c14a9d9b6be1b47c559931e345e9eef8
ToppCell5'-Adult-SmallIntestine-Hematopoietic-B_cells-Naive_B|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

REL BAG3

1.47e-03184142a068ae741889d59937690c11e0bf405481402c25
ToppCellfacs-Limb_Muscle-ForelimbandHindlimb|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

REL BAG3

1.48e-03185142eb7d3c1363d5fedc611f9c1a91ea823de251355e
ToppCellMonocytes-IL1B+_Monocytes|Monocytes / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues

GARIN4 BAG3

1.48e-03185142cbe54b605f417a01b3b5d2ec75565ee3b5a9ba06
ToppCellCOVID-19_Convalescent-Lymphoid_B-B_naive|COVID-19_Convalescent / Disease group, lineage and cell class

GARIN4 REL

1.50e-031861429d339f57036d17572882ebb801f2be9b1d1ddc1c
ToppCell10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

REL BAG3

1.51e-0318714298026c1aaf8de280470ad75536121357934fc78d
ToppCell10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue

REL ARID1B

1.53e-03188142ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)

REL ARID1B

1.53e-03188142d8decd9b5967873ca8320c2f9f07365f163c777f
ToppCell10x5'v1-week_12-13-Myeloid_neutrophil-granulo-eo/baso/mast-basophil|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

REL CLINT1

1.53e-03188142b4d695c373195d389e0a579e9589e87433286b24
ToppCellfacs-Limb_Muscle|facs / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TBX15 BAG3

1.55e-0318914221ec43859d21ffc565acbe36489da1d2d0f9877d
ToppCellControl-Myeloid-cDC2|Control / Disease state, Lineage and Cell class

STK38L REL

1.56e-031901424e481e42353d47af7991744000403af2873f6a41
ToppCellfacs-Tongue-nan-3m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DLG2 CLINT1

1.56e-03190142719a5cecc3e8001ca9c38165258b5ff9c800713a
ToppCellwk_08-11-Epithelial-PNS-Schwann_precursor|wk_08-11 / Celltypes from embryonic and fetal-stage human lung

DLG2 BAG3

1.56e-031901424a777d8aa19cadd3b61b023772df142421a89113
ToppCell10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

REL BAG3

1.56e-031901424d401b73c0e7eb38e95d0851a128bf12bb0d3a9f
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

REL ARID1B

1.56e-031901420724665ac8238f2383c3a929d89abf4a48ec2420
ToppCellControl-Myeloid-cDC2|World / Disease state, Lineage and Cell class

STK38L REL

1.58e-0319114211dfd8f38beb294f42710cfbd355cb089e1023c0
ToppCellfacs-Tongue-nan-18m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DLG2 CLINT1

1.58e-0319114202f24202f9fdd46c648265a5b3b6f9066aa009fc
ToppCell(3)_MNP-(3)_DC_2|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4)

STK38L REL

1.58e-031911423ff163484af8c12ef4eef87246cf044257fd2547
ToppCell10x3'2.3-week_12-13-Myeloid_macrophage-stroma-monocytoid_macrophage|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

STK38L BAG3

1.58e-031911428a67dc87c926c826a09cf6469c8ebf90c80b06db
ToppCellCOVID-19-Myeloid-DC2|COVID-19 / Condition, Lineage and Cell class

STK38L REL

1.58e-031911421304ab7b5713f29f3966ffc020ea1b52e8e2f375
ToppCell10x5'v1-week_14-16-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

TBX15 DLG2

1.58e-0319114244b1f62fdee03b157fe545f2ae6ff84f8929a8ac
ToppCell5'-Adult-SmallIntestine-Hematopoietic-B_cells-Memory_B|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

REL BAG3

1.58e-03191142ce0217d375af6b19252a45340b72241ea7b204d4
ToppCell367C-Myeloid-Dendritic|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

STK38L REL

1.59e-03192142877aaf61d8fc40e7013944a0180306dd0bb0557f
ToppCell356C-Myeloid-Dendritic-cDC2|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

STK38L REL

1.59e-03192142a7ccbea7c90c070d279d7ad3f2b5b7c0e3efd890
ToppCell356C-Myeloid-Macrophage-SPP1+_Macrophage_3|Macrophage / Donor, Lineage, Cell class and subclass (all cells)

REL BAG3

1.59e-03192142f40a7f8771aa9891a6fd59b9c8eac2fd792efa9b
ToppCell367C-Myeloid-Monocyte|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

REL BAG3

1.59e-0319214226326d7c3d907d754e85e128b7d8a52e90863f3f
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)

REL ARID1B

1.59e-03192142446c61c0d6ba89c619efe87ee495951299953981
ToppCellrenal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group

DLG2 ARID1B

1.59e-03192142e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCellPCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

REL BAG3

1.59e-031921426bba80887d6f64cf913a5c22f62baaddda417ce0
ToppCellPCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

REL BAG3

1.59e-031921423f925a80b5e2b0577d573e88598a2984a5f6a789
ToppCelldroplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

DLG2 DLG3

1.61e-0319314264edc1d6fb0fe117767d494cf4a5723bf8be2804
ToppCell367C-Myeloid-Monocyte-CD14+_Monocyte|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

REL BAG3

1.61e-03193142c7ecd98729419b34c14f9b387b15472c47951d2f
ToppCellPCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung

REL BAG3

1.61e-03193142cf3cbf79ccd34ddcf06ec6194a18a7afd7f91f39
ToppCellfacs-Marrow-B-cells-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

REL ARID1B

1.61e-0319314224c34c6635eb7fc2878282803c421b64320e77d8
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)

REL ARID1B

1.61e-03193142bbea475d2c4c7b29674ff302529f8f83dd666dcb
ToppCellCOVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type

STK38L DLG2

1.61e-03193142dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0
ToppCell367C-Myeloid-Dendritic-cDC2|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

STK38L REL

1.61e-03193142940e9a419d0de1f9e72b5cc9c86684057003be58
ToppCellPCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

REL BAG3

1.61e-03193142dbf0fe496254320c894568c31e5f9ce63707d1b5
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

REL ARID1B

1.61e-03193142f4135615ee0118eec9e221becdd67888e0c2a112
ToppCell367C-Myeloid-Dendritic|367C / Donor, Lineage, Cell class and subclass (all cells)

STK38L REL

1.61e-03193142365e831ae6ac67fb36d8d70ef139f4ae7e32c83f
ToppCellfacs-Tongue-nan-3m-Epithelial-keratinocyte|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DLG2 CLINT1

1.61e-0319314233437fdb417d78463caee14a9f0e094da1733829
ToppCell10x5'-Lung-Myeloid_Dendritic-DC2|Lung / Manually curated celltypes from each tissue

STK38L REL

1.61e-03193142c97f9b13057f803df63c696c6175ef8e0aba6fa7
ToppCell10x5'-Lung-Myeloid_Dendritic|Lung / Manually curated celltypes from each tissue

STK38L REL

1.61e-031931427bce609699c515d2d114596a0c527f90cc09c4af
ToppCellControl-Myeloid-cDC2|Myeloid / Disease state, Lineage and Cell class

STK38L REL

1.61e-031931424cb938c346cc32ec122d11e6b9f25db20e0f7ff6
ToppCellSmart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-B_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

REL ARID1B

1.63e-03194142ff661419b697aef51a53fdeac8d37d870d65f491
ToppCellfacs-Tongue-nan-18m-Epithelial-keratinocyte|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DLG2 CLINT1

1.63e-03194142afc997879e031b49d22a85e107c5849140709b44
ToppCell343B-Myeloid-Dendritic-cDC2|343B / Donor, Lineage, Cell class and subclass (all cells)

STK38L REL

1.63e-03194142aa6c9b71006fd3863a802d112d9c3838865a52bf
ToppCell367C-Myeloid-Dendritic-cDC2|367C / Donor, Lineage, Cell class and subclass (all cells)

STK38L REL

1.63e-03194142d0ffba657c7308feecaa62dd54c920d32be0f129
ToppCell368C-Myeloid-Dendritic-cDC2|368C / Donor, Lineage, Cell class and subclass (all cells)

STK38L REL

1.63e-03194142eb9656d6d2da9aa074e6f5c06d750a6f9828208a
ToppCell5'-Adult-SmallIntestine-Hematopoietic-B_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

REL BAG3

1.63e-03194142d4bbae30b9395139c745b71f8a4a356b11223b69
ToppCell368C-Myeloid-Dendritic|368C / Donor, Lineage, Cell class and subclass (all cells)

STK38L REL

1.63e-031941424f88759d92ac229b1edd2d4b69b878bbf2d9b6bd
ToppCellBronchial_Brush-Immune-Dendritic_cells|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X

STK38L REL

1.63e-03194142dbcc00940538efc0f89f074dbe822c50efa5ad8e
ToppCellnucseq-Immune-Immune_Myeloid-Myeloid_Dendritic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

STK38L REL

1.63e-03194142bde6830a281f7cd7fd1733e40a41ddd2673ba88e
ComputationalGenes upregulated in subsets of cells of a given type within various tumors

REL BAG3

7.48e-045092GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_STRESS_HSP
DrugStrophanthidin [66-28-4]; Up 200; 9.8uM; HL60; HT_HG-U133A

REL OVGP1 KAT6A

1.03e-041661332525_UP
DrugLanatoside C [17575-22-3]; Up 200; 4uM; HL60; HT_HG-U133A

REL OVGP1 KAT6A

1.09e-041691332193_UP
DrugN-DM

STK38 CLINT1

1.13e-0428132CID000414013
DrugNocodazole [31430-18-9]; Down 200; 13.2uM; PC3; HT_HG-U133A

SS18 DLG3 KAT6A

1.54e-041901337145_DN
DrugAC1MJ1SO

REL CLINT1

1.57e-0433132CID003084042
DrugBenserazide hydrochloride [14919-77-8]; Down 200; 13.6uM; PC3; HT_HG-U133A

DLG3 CLINT1 OVGP1

1.64e-041941336722_DN
DrugIopanoic acid [96-83-3]; Down 200; 7uM; MCF7; HT_HG-U133A

STK38L SS18 KAT6A

1.64e-041941335448_DN
DrugFlumequine [42835-25-6]; Down 200; 15.4uM; PC3; HT_HG-U133A

SS18 DLG3 KAT6A

1.64e-041941335104_DN
Drugestradiol; Down 200; 0.01uM; PC3; HT_HG-U133A

SS18 DLG3 OVGP1

1.66e-041951335910_DN
DrugCyclizine hydrochloride [303-25-3]; Up 200; 13.2uM; HL60; HG-U133A

STK38L DLG3 OVGP1

1.66e-041951331731_UP
Drugradicicol; Up 200; 0.1uM; PC3; HG-U133A

STK38L OVGP1 BAG3

1.66e-04195133449_UP
DrugAzathymine, 6 [932-53-6]; Down 200; 31.4uM; MCF7; HT_HG-U133A

SS18 OVGP1 KAT6A

1.66e-041951334106_DN
Drug(S)-(-)-Cycloserine [339-72-0]; Down 200; 39.2uM; PC3; HT_HG-U133A

SS18 CLINT1 KAT6A

1.69e-041961333789_DN
DrugLevodopa [59-92-7]; Down 200; 20.2uM; PC3; HT_HG-U133A

SS18 DLG3 OVGP1

1.69e-041961334571_DN
DrugCondelphine [7633-69-4]; Down 200; 8.8uM; PC3; HT_HG-U133A

DLG3 REL OVGP1

1.69e-041961336357_DN
DrugLisuride (S)(-) [18016-80-3]; Down 200; 11.8uM; PC3; HG-U133A

SS18 DLG3 OVGP1

1.71e-041971331962_DN
DrugKaempferol [520-18-3]; Down 200; 14uM; MCF7; HT_HG-U133A

SS18 DLG3 KAT6A

1.71e-041971333579_DN
DrugAjmalicine hydrochloride [4373-34-6]; Down 200; 10.2uM; PC3; HT_HG-U133A

DLG3 REL OVGP1

1.71e-041971336360_DN
DrugNorethynodrel [68-23-5]; Down 200; 13.4uM; MCF7; HT_HG-U133A

DLG3 REL KAT6A

1.76e-041991337471_DN
DrugBupropion hydrochloride [31677-93-7]; Down 200; 14.4uM; PC3; HT_HG-U133A

SS18 DLG3 KAT6A

1.79e-042001335782_DN
Drugrapamycin, Streptomyces hygroscepicus; Down 200; 0.1uM; MCF7; HT_HG-U133A

STK38L SS18 OVGP1

1.79e-042001335927_DN
Drugtricarballylate

STK38 STK38L

5.06e-0459132CID000014925
Drug5'-GMP Na2

DLG2 DLG3 REL

8.09e-04335133CID000000761
DrugCID5192997

STK38 REL

1.12e-0388132CID005192996
DrugZithromac

DLG3 CLINT1

1.42e-0399132CID000002269
Drugp-hydroxymandelonitrile

DLG2 DLG3

1.97e-03117132CID000166768
DrugAC1L9LT0

DLG2 DLG3

2.17e-03123132CID000448294
Drugtrifluralin

CLINT1 OVGP1

2.46e-03131132CID000005569
DrugEnvironmental Pollutants

REL CLINT1 BAG3

2.75e-03513133ctd:D004785
DrugPh-F

REL KAT6A

2.96e-03144132CID000447564
DrugLanatoside C [17575-22-3]; Up 200; 4uM; PC3; HT_HG-U133A

REL OVGP1

3.59e-031591324328_UP
DrugProscillaridin A [466-06-8]; Up 200; 7.6uM; MCF7; HT_HG-U133A

REL KAT6A

3.73e-031621327340_UP
DrugDigitoxigenin [143-62-4]; Up 200; 10.6uM; HL60; HT_HG-U133A

REL KAT6A

3.73e-031621321339_UP
DrugProscillaridin A [466-06-8]; Up 200; 7.6uM; HL60; HT_HG-U133A

REL OVGP1

3.82e-031641322920_UP
DrugMenadione [58-27-5]; Up 200; 23.2uM; HL60; HT_HG-U133A

SS18 BAG3

3.86e-031651322439_UP
DrugHelveticoside [630-64-8]; Up 200; 7.4uM; PC3; HT_HG-U133A

SS18 OVGP1

3.91e-031661324327_UP
DrugDigoxin [20830-75-5]; Up 200; 5.2uM; HL60; HT_HG-U133A

DLG3 REL

4.10e-031701322423_UP
DrugBisacodyl [603-50-9]; Up 200; 11uM; MCF7; HT_HG-U133A

REL KAT6A

4.14e-031711323297_UP
DrugNiclosamide [50-65-7]; Up 200; 12.2uM; HL60; HG-U133A

REL OVGP1

4.19e-031721321998_UP
DrugStrophantine octahydrate [11018-89-6]; Up 200; 5.4uM; HL60; HT_HG-U133A

REL KAT6A

4.29e-031741321302_UP
DrugCiclopirox ethanolamine [41621-49-2]; Up 200; 15uM; HL60; HT_HG-U133A

SS18 BAG3

4.29e-031741322456_UP
Drug15d-PGJ2; Up 200; 10uM; HL60; HT_HG-U133A

SS18 BAG3

4.38e-031761321172_UP
DrugDigoxigenin [1672-46-4]; Up 200; 10.2uM; HL60; HT_HG-U133A

REL OVGP1

4.43e-031771323060_UP
DrugZuclopenthixol hydrochloride [633-59-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A

SS18 REL

4.73e-031831324843_UP
DrugThiostrepton [1393-48-2]; Up 200; 2.4uM; HL60; HT_HG-U133A

DLG3 BAG3

4.78e-031841322462_UP
DrugEllipticine [519-23-3]; Up 200; 16.2uM; HL60; HG-U133A

STK38L BAG3

4.78e-031841321765_UP
DrugLY 294002; Up 200; 10uM; MCF7; HT_HG-U133A

SS18 KAT6A

4.83e-031851326945_UP
DrugRolitetracycline [751-97-3]; Down 200; 7.6uM; MCF7; HT_HG-U133A

SS18 REL

4.83e-031851323369_DN
DrugProgesterone [57-83-0]; Down 200; 12.8uM; HL60; HT_HG-U133A

OVGP1 KAT6A

4.88e-031861322426_DN
DrugGanciclovir [82410-32-0]; Down 200; 15.6uM; MCF7; HT_HG-U133A

SS18 REL

4.93e-031871323368_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A

DLG3 OVGP1

4.93e-031871326671_DN
Drug17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A

OVGP1 BAG3

4.98e-031881326926_UP
DrugPicrotoxinin [17617-45-7]; Down 200; 13.6uM; HL60; HT_HG-U133A

SS18 CLINT1

4.98e-031881322161_DN
Diseasebenign neoplasm (implicated_via_orthology)

DLG2 DLG3

5.01e-068132DOID:0060072 (implicated_via_orthology)
Diseasecancer (implicated_via_orthology)

DLG2 DLG3 ARID1B

1.98e-04268133DOID:162 (implicated_via_orthology)
Diseasedevelopmental disorder of mental health (implicated_via_orthology)

DLG2 DLG3

2.08e-0449132DOID:0060037 (implicated_via_orthology)
Diseaseresponse to cranial radiation therapy, short-term memory

DLG2 ARID1B

3.13e-0460132EFO_0004335, EFO_0010950
Diseasecarcinoma (implicated_via_orthology)

DLG2 DLG3

3.56e-0464132DOID:305 (implicated_via_orthology)
Diseaset-tau:beta-amyloid 1-42 ratio measurement

DLG2 OVGP1

3.78e-0466132EFO_0007708
Diseaseplatelet component distribution width

STK38 DLG3 CLINT1

3.94e-03755133EFO_0007984
Diseaseperiodontitis

SS18 DLG2

4.20e-03223132EFO_0000649
DiseaseMajor Depressive Disorder

DLG2 DLG3

4.96e-03243132C1269683
DiseaseUnipolar Depression

DLG2 DLG3

5.62e-03259132C0041696
Diseasesoluble triggering receptor expressed on myeloid cells 2 measurement

TBX15 STK38L

7.27e-03296132EFO_0010151
DiseaseQRS duration

DLG2 BAG3

7.37e-03298132EFO_0005055
DiseaseParkinson disease

DLG2 BAG3

8.50e-03321132MONDO_0005180
Diseasemean platelet volume

STK38 STK38L DLG3

9.08e-031020133EFO_0004584
DiseaseMyopia

DLG2 ARID1B

1.20e-02385132HP_0000545

Protein segments in the cluster

PeptideGeneStartEntry
GNMSSMTPSSPGMSQ

ARID1B

981

Q8NFD5
LMGSSQATMTSSQSM

CLINT1

426

Q14677
TAQSGSSMSMFNTTM

GARIN4

11

Q8IYT1
SMGSSCSMMQQSSVQ

KAT6A

1611

Q92794
REQMMNSSMSSGSGS

DLG3

481

Q92796
TAQSSPAMGMFNTSM

GARIN6

11

Q8NEG0
REQMMNHSMSSGSGS

DLG2

516

Q15700
MSAATHSPMMQVASG

BAG3

1

O95817
AMTMTSVGHQSMTPG

OVGP1

476

Q12889
MAMTGSTPCSSMSNH

STK38

1

Q15208
MAMTAGTTTTFPMSN

STK38L

1

Q9Y2H1
MQAGNAASSSSSPHM

TBX15

481

Q96SF7
TNSSMNMPSSSHGSM

SS18

146

Q15532
LHQMSSSSMSAGANS

REL

536

Q04864